Stock 600566 HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hubei Jumpcan Pharmaceutical Co., Ltd.

Equities

600566

CNE0000018X6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-02 pm EDT 		5-day change 1st Jan Change
32.38 CNY -0.92% Intraday chart for Hubei Jumpcan Pharmaceutical Co., Ltd. -0.31% +3.02%
Jun. 27 Hubei Jumpcan Pharmaceutical Obtains Drug Registration for Antibiotic Injection; Shares Down 3% MT
Jun. 20 Hubei Jumpcan Pharmaceutical Gets Drug Registration Certificate for Allergy Drug; Shares Slide 3% MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,705 17,969 25,173 25,092 28,972 30,125 - -
Enterprise Value (EV) 1 19,705 17,969 25,173 25,092 28,972 30,125 30,125 30,125
P/E ratio 12.2 x 13.2 x 14.8 x 11.4 x 10.2 x 9.88 x 8.82 x 7.98 x
Yield 5.09% - - - - - - -
Capitalization / Revenue 2.84 x 2.91 x 3.3 x 2.79 x 3 x 3 x 2.77 x 2.57 x
EV / Revenue 2.84 x 2.91 x 3.3 x 2.79 x 3 x 3 x 2.77 x 2.57 x
EV / EBITDA - - 11.3 x 9.16 x 9.03 x 8.45 x 7.67 x 7.05 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 3.23 x 2.35 x 2.79 x 2.21 x 2.17 x 1.89 x 1.6 x 1.37 x
Nbr of stocks (in thousands) 814,922 888,257 888,259 921,822 921,807 921,807 - -
Reference price 2 24.18 20.23 28.34 27.22 31.43 32.68 32.68 32.68
Announcement Date 3/12/20 4/16/21 1/19/22 1/19/23 4/9/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,940 6,165 7,631 8,996 9,655 10,042 10,860 11,709
EBITDA 1 - - 2,226 2,740 3,209 3,565 3,926 4,275
EBIT 1 1,858 1,469 1,933 2,423 3,258 3,504 3,913 4,344
Operating Margin 26.77% 23.83% 25.33% 26.94% 33.75% 34.9% 36.03% 37.1%
Earnings before Tax (EBT) 1 1,893 1,484 1,950 2,508 3,297 3,544 3,968 4,390
Net income 1 1,623 1,277 1,719 2,171 2,823 3,047 3,412 3,773
Net margin 23.39% 20.72% 22.53% 24.13% 29.24% 30.34% 31.41% 32.23%
EPS 2 1.990 1.530 1.910 2.390 3.080 3.307 3.703 4.097
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 1.230 - - - - - - -
Announcement Date 3/12/20 4/16/21 1/19/22 1/19/23 4/9/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 28.4% 19.9% 20.5% 21.9% 23% 19.1% 18.1% 17.2%
ROA (Net income/ Total Assets) - - - - - 14.2% 13.8% 13.2%
Assets 1 - - - - - 21,458 24,722 28,586
Book Value Per Share 2 7.490 8.630 10.20 12.30 14.50 17.30 20.50 23.90
Cash Flow per Share 2 2.640 2.010 2.130 2.840 3.760 2.860 3.660 4.090
Capex 1 546 - - - - 306 271 255
Capex / Sales 7.86% - - - - 3.04% 2.5% 2.17%
Announcement Date 3/12/20 4/16/21 1/19/22 1/19/23 4/9/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
32.68 CNY
Average target price
52.36 CNY
Spread / Average Target
+60.22%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. Stock Hubei Jumpcan Pharmaceutical Co., Ltd.
+3.98% 4.14B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.55% 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.88% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.83% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.15% 323B
ABBVIE INC. Stock AbbVie Inc.
+7.09% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.51% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+1.60% 222B
NOVARTIS AG Stock Novartis AG
+13.53% 218B
AMGEN INC. Stock Amgen Inc.
+7.87% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600566 Stock
  4. Financials Hubei Jumpcan Pharmaceutical Co., Ltd.